Overview
ICCM market data
Price History
ICCM price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$7.11 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.47 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -441.6% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $2.12 – $42.00 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $9.1M · P/B 4.63 · P/S 2.56.
Company News
IceCure Medical Highlights Peer‑Reviewed Publications Reinforcing Cryoablation’s Growing Clinical Role In Breast Cancer Treatment De‑Escalation, Including FDA Authorization Of ProSense, Updated ASBrS Guidelines, And Positive ICE3 5‑Yr OutcomesBenzinga · Aug 13, 2026, 1:14 PM
Icecure Medical Q2 EPS $(1.37) Beats $(1.40) Estimate, Sales $889.000K Miss $1.450M EstimateBenzinga · Aug 12, 2026, 1:36 PM
12 Health Care Stocks Moving In Friday's After-Market SessionBenzinga · Aug 7, 2026, 9:05 PM
IceCure Medical Announced Adventist Health Glendale Signed Agreement, Received IRB Approval To Become First Clinical Site To Enroll Patients In Post-Marketing ChoICE Study For ProSense In Local Treatment Of Low-Risk Breast CancerBenzinga · Aug 6, 2026, 12:09 PM
IceCure Medical Announces That The Society Of Interventional Oncology Submitted A Petition To The National Comprehensive Cancer Network Breast Cancer Guidelines Panel To Include Percutaneous Cryoablation Without Surgical Excision As An Option For Breast CancerBenzinga · Jul 29, 2026, 12:29 PM
IceCure Medical Notes Growing International Interest In Its ProSense System In BrazilBenzinga · Jul 6, 2026, 12:20 PM
12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga · Jun 26, 2026, 5:10 PM
What's Going On With IceCure Medical Stock On Friday?Benzinga · Jun 26, 2026, 2:05 PM
IceCure Medical Regains Nasdaq ComplianceBenzinga · Jun 25, 2026, 12:20 PM
KB Home Posts Upbeat Q2 Sales, Joins Inmode, Icon And Other Big Stocks Moving Higher On WednesdayBenzinga · Jun 24, 2026, 2:00 PM